RE:RE:RE:RE:New 52 week low Worst case they can always sell a project, like the Abbvie contract.
There will not be a default since there are unleashed value in the projects and scientific platform.
The first sell-off was triggered by the private placement that was reckless to launch just after securing a loan and positive NR round the corner. The management should be blamed.
For some strange reason people started to sell triggered by the AGM, which is a non-event. There hasn't been any material NR in conjunction to the AGM and it will never be. This one is on us as shareholders.
But in the end of the day there's good enough value in the company to ensure most if not all investors to end up even in the worst case. The share price does not reflect current value.